Clinical Report: Prolonged Endocrine Treatment and Outcomes for Breast Cancer Subtypes in Premenopausal Women
Overview
This study evaluates the impact of extended endocrine therapy (EET) on recurrence rates in premenopausal women with node-positive, hormone receptor-positive early breast cancer. Findings suggest that EET may significantly reduce invasive and distant recurrence rates in this population.
Background
Incorporate statistics or references to support claims about the prognosis of younger breast cancer patients.
Data Highlights
Replace placeholder text with relevant data or clarify that no data is available.
Key Findings
Extended endocrine therapy (EET) is associated with lower rates of invasive and distant recurrence in premenopausal women with node-positive, hormone receptor-positive breast cancer.
More than 70% of premenopausal patients remain recurrence-free 10 years after completing 5 years of LHRH agonist-based therapy.
Patterns of recurrence differ significantly across luminal breast cancer subtypes, impacting the efficacy of EET.
Patients with luminal B-like tumors exhibit a higher early risk of recurrence compared to luminal A-like tumors.
Triple-positive breast cancer patients experience a more gradual accumulation of recurrences, with risks concentrated in the first 5 years.
Clinical Implications
Clinicians should consider the subtype of breast cancer when recommending extended endocrine therapy for premenopausal patients. The potential benefits of EET in reducing recurrence rates highlight the importance of personalized treatment strategies based on individual risk profiles.
Conclusion
The findings underscore the importance of extended endocrine therapy in improving outcomes for premenopausal women with hormone receptor-positive breast cancer. Further research is needed to refine candidate selection for EET based on tumor biology.
by Carmine Valenza, Yue Zheng, Monica Milano, Pier Paolo Maria Berton Giachetti, Dario Trapani, Elisa Giordano, Lorenzo Guidi, Laura Boldrini, Grazia Castellano, Jalissa Katrini, Bianca Malagutti, Gabriele Antonarelli, Julian D. Etessami, Nadia Bianco, Fabio Conforti, Gregory J. Kirkner, Claudia Sangalli, Kate E. Dibble, Nicola Fusco, Marco Colleoni, Meredith M. Regan, Elisabetta Munzone, Giuseppe Curigliano, Ann H. Partridge
